Stay updated on Efficacy of LOU064 in Asthma Patients Clinical Trial

Sign up to get notified when there's something new on the Efficacy of LOU064 in Asthma Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of LOU064 in Asthma Patients Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 19 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T14:06:29.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:59:55.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T13:41:59.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients.
    Difference
    0.1%
    Check dated 2024-06-27T09:49:02.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:42:24.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less MedlinePlus related topics: Asthma FDA Drug and Device Resources Show less Design Details Primary Purpose : Treatment Allocation : Randomized Interventional Model : Parallel Assignment Masking : Quadruple ( Participant Care Provider Investigator Outcomes Assessor ) Arms and Interventions Participant Group/Arm Intervention/Treatment Experimental : LOU064 LOU064 100 mg once daily orally Drug : LOU064 100 mg LOU064 100 mg once daily orally administered as two 50 mg capsules Placebo Comparator : Placebo Placebo once daily orally Drug : Placebo Placebo once daily administered orally as capsules Primary Outcome Measures Outcome Measure Measure Description Time Frame Change From Baseline in Pre-dose FEV1 at Week 12 FEV1 (forced expiratory volume in one second) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing. Pre-dose FEV1 is defined as average of the two FEV1 measurements taken 45 min and 15 min pre-dose. The baseline pre-dose FEV1 is defined as the average of the FEV1 measurements performed 45 min and 15 min prior to dosing on Day 1. A positive change from baseline in pre-dose FEV1 is considered a favorable outcome. Change from baseline in pre-dose FEV1 was analyzed using a Bayesian model for repeated measures, adjusting for effects of treatment*visit interaction and baseline pre-dose FEV1. A weakly informative prior was considered for the placebo response. Baseline, Week 12'
    Difference
    61%
    Check dated 2024-06-25T08:15:51.000Z thumbnail image

Stay in the know with updates to Efficacy of LOU064 in Asthma Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of LOU064 in Asthma Patients Clinical Trial page.